Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CRLF1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | UBE2B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | C1orf21 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | MEPCE | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | EPS8 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PRDX5 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | USP31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CTD-2349B8.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | FMR1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | LRRN4CL | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |